Published online before print December 12, 2005, doi: 10.1161/CIRCULATIONAHA.105.549857
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:3884-3891.)
© 2005 American Heart Association, Inc.
Epidemiology |
Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use
The Minnesota Heart Survey, 1980–1982 to 2000–2002
From the Department of Epidemiology, University of Alabama at Birmingham (D.K.A.); the Division of Epidemiology and Community Health, University of Minnesota, Minneapolis (D.R.J., R.V.L., H.B., C.A., S.A.C.); and the Department of Nutrition, University of Oslo, Oslo, Norway (D.R.J.).
Correspondence to Donna K. Arnett, PhD, Department of Epidemiology, University of Alabama at Birmingham, 1665 University Blvd, Birmingham, AL. E-mail arnett{at}uab.edu
Received March 17, 2005; revision received September 16, 2005; accepted October 5, 2005.
Background— Although US cholesterol concentrations have dropped, &50% of adults have total cholesterol concentrations 
5.18 mmol/L, putting them at "borderline-high risk" for heart disease. Whether the decline has continued into the 21st century is unknown. We assessed 20-year trends in cholesterol, hypercholesterolemia, lipid-lowering drug use, and cholesterol awareness, treatment, and control from Minnesota Heart Survey (MHS) data.
Methods and Results— Five independent, cross-sectional, population-based surveys of 2500 to 5000 adults were conducted in the Minneapolis–St. Paul, Minn, area from 1980 to 2002. Mean (nonfasting) total cholesterol concentrations have continued a 20-year decline, punctuated by an intervening lull. Age-adjusted mean total cholesterol concentrations in 2000 to 2002 were 5.16 and 5.09 mmol/L for men and women, respectively (in 1980 to 1982, 5.49 and 5.38 mmol/L for men and women, respectively) However, the decline has not been uniform across all age groups. Middle-aged to older people have shown substantial decreases, but younger people have shown little overall change and recently had increased total cholesterol values. The mean prevalence of hypercholesterolemia in 2000 to 2002 was 54.9% for men and 46.5% for women and has decreased significantly for both during the study. Age-adjusted mean high-density lipoprotein cholesterol concentrations in 2000 to 2002 were 1.09 and 1.40 mmol/L for men and women, respectively, and were not different from the prior survey. Lipid-lowering drug use rose significantly for both sexes aged 35 to 74 years. Awareness, treatment, and control of hypercholesterolemia have increased; however, more than half of those at borderline-high risk remain unaware of their condition.
Conclusions— Although hypercholesterolemia prevalence continued to fall, significant population segments still have cholesterol concentrations near or at the level of increased risk.
CLINICAL PERSPECTIVE
Find additional patient-related information at:
This article has been cited by other articles:
 |
|
 |
|
  H. J. Chin, J. M. Ahn, K. Y. Na, D.-w. Chae, T. W. Lee, N. J. Heo, and S. Kim The effect of the World Kidney Day campaign on the awareness of chronic kidney disease and the status of risk factors for cardiovascular disease and renal progression Nephrol. Dial. Transplant., September 25, 2009; (2009) gfp512v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Monda, C. M. Ballantyne, and K. E. North Longitudinal impact of physical activity on lipid profiles in middle-aged adults: the Atherosclerosis Risk in Communities Study J. Lipid Res., August 1, 2009; 50(8): 1685 - 1691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Solomon, D. P. Goldman, G. F. Joyce, and J. J. Escarce Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill Arch Intern Med, April 27, 2009; 169(8): 740 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ingelsson, J. M. Massaro, P. Sutherland, P. F. Jacques, D. Levy, R. B. D'Agostino, R. S. Vasan, and S. J. Robins Contemporary Trends in Dyslipidemia in the Framingham Heart Study Arch Intern Med, February 9, 2009; 169(3): 279 - 286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Gidal, J. A. French, P. Grossman, and G. Le Teuff Assessment of potential drug interactions in patients with epilepsy: Impact of age and sex Neurology, February 3, 2009; 72(5): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Myerson, S. Coady, H. Taylor, W. D. Rosamond, D. C. Goff Jr, and for the ARIC Investigators Declining Severity of Myocardial Infarction From 1987 to 2002: The Atherosclerosis Risk in Communities (ARIC) Study Circulation, February 3, 2009; 119(4): 503 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Erbel, J. A.C. Delaney, N. Lehmann, R. L. McClelland, S. Mohlenkamp, R. A. Kronmal, A. Schmermund, S. Moebus, N. Dragano, A. Stang, et al. Signs of subclinical coronary atherosclerosis in relation to risk factor distribution in the Multi-Ethnic Study of Atherosclerosis (MESA) and the Heinz Nixdorf Recall Study (HNR) Eur. Heart J., November 2, 2008; 29(22): 2782 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kitamura, S. Sato, M. Kiyama, H. Imano, H. Iso, T. Okada, T. Ohira, T. Tanigawa, K. Yamagishi, M. Nakamura, et al. Trends in the incidence of coronary heart disease and stroke and their risk factors in Japan, 1964 to 2003 the akita-osaka study. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 71 - 79. [Full Text] [PDF]
|
|
|
|
|
|
Writing Group Members, W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Geller, S. Cassens, M. Brosz, U. Keil, J. Bernarding, S. Kropf, R. A. Bierwirth, B. Lippmann-Grob, H.-P. Schultheiss, K. Schluter, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study Eur. Heart J., December 2, 2007; 28(24): 3051 - 3058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF]
|
|
|
|
|
|
H. M. Krumholz and F. A. Masoudi The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1886 - 1895. [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gotto Jr Over-The-Counter Statins Are Worth Considering in Primary Prevention of Cardiovascular Disease Circulation, September 19, 2006; 114(12): 1310 - 1314. [Full Text] [PDF]
|
|